Subsequently, Patel et al. published a case report reporting the successful use of eculizumab, a humanized monoclonal antibody that inhibits cleavage of C5 by C5 convertase, in a 34-year-old female diagnosed with IgA vasculitis complicated by acute kidney failure [31]. This evidence concerns the gene C5 and Henoch-Schoenlein purpura.